Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo.

Authors

Fadi J Najm
Mayur Madhavan
Anita Zaremba
Elizabeth Shick
Robert T Karl
Robert H. Miller, George Washington UniversityFollow
+17 additional authors

Document Type

Journal Article

Publication Date

6-11-2015

Journal

Nature

Volume

522

Issue

7555

Inclusive Pages

216-220

DOI

10.1038/nature14335

Keywords

Animals; Cell Differentiation; Cerebellum; Clobetasol; Demyelinating Diseases; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Female; Germ Layers; Humans; Lysophosphatidylcholines; MAP Kinase Signaling System; Male; Mice; Miconazole; Mitogen-Activated Protein Kinases; Multiple Sclerosis; Myelin Sheath; Oligodendroglia; Phenotype; Pluripotent Stem Cells; Receptors, Glucocorticoid; Regeneration; Tissue Culture Techniques

Comments

This is an open access PubMed Central article. Click on link for full-text access.

APA Citation

Najm, F., Madhavan, M., Zaremba, A., Shick, E., Karl, R., Miller, R. H., & +17 additional authors (2015). Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo.. Nature, 522 (7555). http://dx.doi.org/10.1038/nature14335

Peer Reviewed

1

Open Access

1